Serum Institute of India Gets COVID-19 Vaccine ‘Covishield’ Purchase Order From Centre
"We have received the (purchase) order from the Government of India on Monday afternoon," a senior SII official told PTI. The government has already announced that the process of administering the vaccine will start on on January 16.
Pune, January 11: The Serum Institute on India on Monday said it has received the purchase order from the Centre for the Oxford-AstraZeneca COVID-19 vaccine.
"We have received the (purchase) order from the Government of India on Monday afternoon," a senior SII official told PTI. The government has already announced that the process of administering the vaccine will start on on January 16. COVID-19 Vaccine Price and Latest Update: Covishield, Priced at Rs 200 Per Vial, Ordered by Indian Government, Says Serum Institute of India.
The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)